Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy

Epilepsy Res. 2006 Oct;71(2-3):229-32. doi: 10.1016/j.eplepsyres.2006.06.015. Epub 2006 Aug 4.

Abstract

Plasma total homocysteine (p-tHcy), serum folate (s-F), serum vitamin B-12 (s-B12) and plasma pyridoxal-5'-phosphate (p-PLP) were measured in epileptic children before and after a 20-week period of sodium valproate (group A, n=32) and carbamazepine (group B, n=20) monotherapy. P-tHcy significantly increased in both groups, s-F and s-B12 significantly increased in group A, while s-F and p-PLP significantly decreased in group B. Our study showed an early effect of antiepileptic drug treatment on homocysteine metabolism.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anticonvulsants / pharmacology*
  • Anticonvulsants / therapeutic use
  • Carbamazepine / pharmacology*
  • Carbamazepine / therapeutic use
  • Child
  • Child, Preschool
  • Epilepsy / drug therapy*
  • Epilepsy / metabolism
  • Female
  • Folic Acid / blood
  • Homocysteine / metabolism*
  • Humans
  • Male
  • Prospective Studies
  • Pyridoxal Phosphate / blood
  • Valproic Acid / pharmacology*
  • Valproic Acid / therapeutic use
  • Vitamin B 12 / blood

Substances

  • Anticonvulsants
  • Homocysteine
  • Carbamazepine
  • Pyridoxal Phosphate
  • Valproic Acid
  • Folic Acid
  • Vitamin B 12